News
29m
With multiple deals still in flux and the August 1 deadline fast approaching, Trump’s trade agenda in Asia is nearing a ...
London-listed AstraZeneca, known for its treatments for cancer, diabetes, and Covid-19, will invest $50 billion in U.S. facilities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback